for RNA extraction. The procedures for RNA extraction were done as described. b, 3 Approximately 5 g of RNA was used for RT with Moloney murine leukemia virus reverse transcriptase b by standard methods. 13 PCR was performed with Taq polymerase c also by standard methods. 13 The concentration of primer for RT and PCR was 0.5 M. The amplification product was predicted to be approximately 1 kilobase (kb) long. The amplification product from the virus propagated in vitro was the appropriate size.
To verify the identity of the amplification product and confirm the specificity of these primers, the DNA product from amplification of strain UCD1 was cloned into the p-CRII vector using the TA cloning method d according to the manufacturer's directions. The base sequence of cloned cDNA was determined by the dideoxy chain termination method using 35 S-ATP e with standard methods. 13 The product had 78% homology to the published sequence for the 7a/7b ORF of FECV strain 79-1683 (data not shown). 17 Primers 3, 4, 5, and 6 were designed from the cDNA sequence data (Fig. 1) . Primers 3 and 4 were used in the second round of PCR on 5 l of the product from the first round of amplification using the same parameters as for the first round of PCR. Primers 5 and 6 were used for nucleotide sequencing of amplification products.
The nested PCR procedure was done also with materials containing other feline viruses that could be present in biologic samples and with feline leukocyte RNA to confirm the specificity of the primers for FCV. These viruses included feline calicivirus, f feline herpesvirus-1, f feline immunodeficiency virus, a feline leukemia virus, a and feline syncytial virus. a Uninfected leukocytes used in primer specificity testing were from a healthy cat seronegative for FIPV.
Primer specificity was high because no product was produced with uninfected leukocyte RNA or RNA from cell cultures infected with the heterologous viruses (data not shown).
To evaluate the sensitivity of the amplification, FIPV strain UCD1 was titrated and quantified for infectivity and by PCR. Virus titer was the reciprocal of the highest dilution of virus per unit volume that resulted in cytopathic effects in 50% of inoculated cells (CCID 50 /ml). Using 1 round of amplification, Ն300,000 CCID 50 /ml could be detected. However, by adding a second round of amplification using the internal primers (primers 3 and 4), Ն30 CCID 50 /ml could be detected (Table 1) .
Clinical samples were evaluated for the presence of FCV RNA by RT-nested PCR. A variety of samples from affected and healthy cats were subjected to RNA extraction, RT, and 2 rounds of amplification. Samples from cats suspected of having FIP were acquired from area veterinarians and included ascitic fluid, pleural fluid, serum, plasma, whole blood, and tissue samples. Fecal samples from healthy cats were obtained from an area cattery that had a history of FIP. 
Two hundred fifty microliters of fluid samples (serum, whole blood, effusion fluid) that had been stored at Ϫ70 C were used for RNA extraction. At least 1 ml of fecal sample was diluted 1:1 (vol:vol) in cell culture medium, mixed thoroughly, and centrifuged at 600 ϫ g for 5 minutes to pellet insoluble debris, and 250 l of the supernatant fluid was used for RNA extraction. Tissue samples of at least 1 ml were homogenized in cell culture medium (1:1, vol:vol) and centrifuged at 600 ϫ g, and 250 l of the supernatant fluid was used for RNA extraction. RNA extraction of all biologic samples was done with Trizol LS b according to the manufacturer's directions. Ten micrograms of glycogen g was added to the 250 l of biologic sample prior to the addition of Trizol LS. All RNA isolated from biologic samples was used for RT followed by PCR. The amplification products were approximately 1 kb in size (Fig. 2) . Amplification products from clinical specimens were identified by nucleotide sequencing of a randomly selected portion using an automated sequencer, h confirming them as the 7a/7b ORFs of FCV (11 of 17 samples from PCR-positive cats; data not shown).
The clinically affected cats also were tested by additional diagnostic assays, including antigen detection by immunofluorescence, serologic assay for FCV-specific antibody, and histopathology. Antigen detection was done by standard methods on conjunctival scrapings of the third eyelid (antemortem) or tissue impressions (postmortem). 2 Results were reported as positive for antigen, negative for antigen, or inconclusive (a slight fluorescence was observed in only 1 or 2 cells, making confirmation of FIPV infection difficult). Serology for FCV-specific antibodies was done by indirect immunofluorescence by standard methods using FIPV WSU1143 propagated in Crandell feline kidney cells as the antigen. 2 Antibody titers were defined as the highest dilution that resulted in fluorescence. A titer of Ն1:640 was considered maximal, and a titer of Ͻ1:40 was considered negative. Results of histopathologic examination of a variety of tissue samples were reported as lesions diagnostic of FIP, negative for FIP, or inconclusive (lesions in 1 or few tissues that were consistent with those described in classical cases of FIP but that lacked some significant diagnostic features). 9 Feces from 1 cat ( Table 2 , cat 5) were examined by electron microscopy following preparation by standard methods. i This cat had numerous coronavirus-like particles present in the feces.
The results of the nested PCR on samples from affected cats are given in Table 2 . Of the 27 cats, 11 were positive for FCV by PCR. Unfortunately, samples available for some of the cats were limited.
All cats that were histologically negative for FIP (n ϭ 6) also were negative by PCR. Six of 7 cats in which FIP was confirmed by histopathology were positive by PCR. Serum was the only sample available for the single PCR-negative, histopathology-positive cat. Of 8 cats inconclusive for FIP by histopathology, 3 were positive by PCR, and 2 of these 3 had significant antibody titers. Of the remaining 5 cats (PCR negative, histopathology inconclusive), antibody titers for the 4 that were tested were insignificant.
The results of the nested PCR assay using effusive fluid correlated with histopathology results, i.e., cats with histopathologic changes diagnostic of FIP were PCR positive and cats with no FIP-specific lesions were PCR negative. Positive PCR results were more consistently obtained with effusive fluid than with any other sample, closely followed by results with plasma and whole blood ( Table 2) . Serum yielded positive PCR results from only 1 of the 7 PCR-positive cats from which serum was available. The data indicate that serum is a poor sample for PCR and often is negative for FCV-infected cats.
Tissue immunofluorescence did not correlate with PCR or histopathology results; results were negative or inconclusive in all cases. FIP-specific antibody levels were significant (titers Ͼ 1:320) for only 4 of the 9 PCR-positive cats for which serology results were available. Antibody titers were significant for only 2 of the 6 histopathology-positive cats for which serology results were available. Insignificant or undetectable antibody titers were noted for 4 of 4 histopathology-negative cats for which serology results were available. One PCR-positive, seronegative animal for which histopathology results were not available was confirmed as FCV infected by electronmicroscopy. This finding confirms data collected over several years in the Clinical Virology laboratory at the University of Tennessee College of Veterinary Medicine that low FCV-specific antibody levels must be interpreted with caution (unpublished). Other investigators have also questioned the value of serology. 4, 15 The PCR assay on effusion fluid or plasma could offer a useful antemortem test for FIP with the accuracy of histopathology but without the risks of biopsy.
Fourteen fecal samples from healthy cats housed in a cattery with a history of FIP-related deaths (confirmed by histopathology; data not given) also were tested by RT-nested PCR. Six of these cats were positive, and the products were the same size as products from cats suspected to have FIP (Fig. 3) . A previous report identified a deletion of approximately 250 nucleotides in the 7b ORF of a putatively avirulent FCV (strain 79-1683). 17 If this deletion in FECV 7b ORF represented a consistent feature of avirulent FCVs, it would allow distinction between FIPV and FECV. However, subsequent investigation has indicated that this deletion does not occur in all FECV isolates, 6 based on sequence comparison of 7 virulent and 5 avirulent FCV laboratory strains. Sixteen field strains, 12 of which were associated with FIP, also were examined, and deletions in the 7b ORF were not detected. This observation was confirmed by the data presented here; all PCR products from biologic samples regardless of the health status of the cats sampled were approximately 1 kb in length. Products derived from clinically ill cats, healthy cats, and nondomestic felids were of similar size. No conserved genomic deletions were detected. Sequence analysis of the amplification products of the 7a/7b ORF from clinical samples is ongoing to determine whether conserved nucleotide sequence differences may exist between virulent and avirulent FCV biotypes. Analysis of amplification products from clinical samples would avoid spurious data introduced by in vitro propagation of the virus.
The RT-nested PCR technique is a sensitive and specific tool for detecting FCV in biologic samples. The findings presented here support those of a recent study, 5 in which FCV was detected in feces, tissues, and body fluids of cats using RT-nPCR targeting the highly conserved 3Ј-untranslated region. In the present study, the 7a/7b ORF was amplified in an attempt to determine if consistent genomic differences occur in this region between FCV biotypes. The previous assay was of similar sensitivity and specificity to the assay reported here. In addition, the test described here included heterologous viruses that may be present in clinical samples so that its specificity for FCV could be confirmed. The data reported here also support the results of the previous study in that the type of sample submitted is an important determinant of the PCR results. No consistent difference between FECV and FIPV could be identified, indicating that this assay is unable to distinguish these viruses. However, the test may be useful for FCV detection as an aid to suspected FIP diagnosis. To confirm the utility of this procedure, large numbers of plasma and effusion samples from cats in different geographic locales must be tested by RT-nested PCR and the results compared with those of histopathology. In addition, this method is useful for genomic characterization of FCV isolates and for molecular epidemiology. This and other regions of the FCV genome in isolates from domestic and nondomestic cats are the targets of current research.
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